$MBX SEC Filings

Filed On	Filing
22 Oct 2026	Form 4: Radovich Peter, Director Granted 18,200 Stock option (right to buy)
22 Oct 2026	Form 3: Radovich Peter, Director No securities owned
22 Oct 2026	8-K: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers Effective as of October 20, 2026, the board of directors (the “Board”) of MBX Biosciences, Inc. (the “Company”), upon the recommendation of the Nominating and Corporate Governance Committee of the Board (the “NCG Committee”), appointed P...
27 Aug 2026	8-K: Regulation FD Disclosure; Other Events
17 Aug 2026	144
14 Aug 2026	SCHEDULE 13G/A
10 Aug 2026	SCHEDULE 13D/A
10 Aug 2026	SCHEDULE 13D/A
06 Aug 2026	10-Q
06 Aug 2026	8-K: Results of Operations and Financial Condition; Regulation FD Disclosure +1 more
05 Aug 2026	Form 4: Azoulay Salomon, Chief Medical Officer Sold 370 shares ($24.3K)
04 Aug 2026	144
04 Aug 2026	144
04 Aug 2026	Form 4: Smither John W, Chief Financial Officer Received 28,000 shares as a grant or award · Granted 130,000 Stock option (right to buy)
04 Aug 2026	Form 4: Hoerter Steven L., Director Received 71,000 shares as a grant or award · Granted 331,000 Stock option (right to buy)
29 Jul 2026	SCHEDULE 13G
13 Jul 2026	8-K: Departure/Election of Directors or Officers; Compensation
08 Jul 2026	SCHEDULE 13G/A
08 Jul 2026	SCHEDULE 13G/A
24 Jun 2026	SCHEDULE 13G

Comments